US 8795656
Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8795656 (Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody) held by Klinikum der Universität Regensburg expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Klinikum der Universität Regensburg
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P19/02